OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE was reported 182 times

These side effects are most commonly reported by patients taking OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE:

# Side effect Count
0 FATIGUE 17
1 DIARRHOEA 15
2 ASTHENIA 14
3 DIZZINESS 12
4 DRUG INEFFECTIVE 10
5 NAUSEA 10
6 VOMITING 9
7 HEADACHE 8
8 OFF LABEL USE 8
9 PRODUCT DOSE OMISSION ISSUE 8
10 DECREASED APPETITE 7
11 DYSPNOEA 7
12 FEELING ABNORMAL 7
13 HYPERTENSION 7
14 PAIN 7
15 GAIT DISTURBANCE 6
16 HOT FLUSH 6
17 MALAISE 6
18 PERIPHERAL SWELLING 6
19 PRODUCT ODOUR ABNORMAL 6
20 RASH 6
21 WEIGHT DECREASED 6
22 CHEST PAIN 5
23 CONFUSIONAL STATE 5
24 DEATH 5
25 PAIN IN EXTREMITY 5
26 PSORIASIS 5
27 SPRUE-LIKE ENTEROPATHY 5
28 ABDOMINAL PAIN UPPER 4
29 ANAEMIA 4
30 ANXIETY 4
31 BLOOD PRESSURE INCREASED 4
32 CONDITION AGGRAVATED 4
33 DRUG ABUSE 4
34 DRY SKIN 4
35 HYPOAESTHESIA 4
36 ILLNESS 4
37 MYALGIA 4
38 POLLAKIURIA 4
39 SYNCOPE 4
40 ARTHRALGIA 3
41 BACK PAIN 3
42 BALANCE DISORDER 3
43 BASAL CELL CARCINOMA 3
44 BONE PAIN 3
45 BRAIN FOG 3
46 BRONCHITIS 3
47 CARDIAC ARREST 3
48 COMPLETED SUICIDE 3
49 CONSTIPATION 3
50 DERMATITIS ATOPIC 3
51 DISCOMFORT 3
52 DRUG INTERACTION 3
53 DYSPEPSIA 3
54 FALL 3
55 GASTROINTESTINAL DISORDER 3
56 GENERALISED OEDEMA 3
57 HYPOKALAEMIA 3
58 INJECTION SITE ERYTHEMA 3
59 INSOMNIA 3
60 MEMORY IMPAIRMENT 3
61 MUSCLE SPASMS 3
62 MUSCULAR WEAKNESS 3
63 NASOPHARYNGITIS 3
64 OEDEMA PERIPHERAL 3
65 PRODUCT SUBSTITUTION ISSUE 3
66 PRODUCT TASTE ABNORMAL 3
67 PRURITUS 3
68 RHABDOMYOLYSIS 3
69 SWELLING 3
70 TACHYCARDIA 3
71 TOXICITY TO VARIOUS AGENTS 3
72 TREATMENT NONCOMPLIANCE 3
73 URINARY TRACT INFECTION 3
74 URTICARIA 3
75 WEIGHT INCREASED 3
76 ABDOMINAL DISCOMFORT 2
77 ABDOMINAL DISTENSION 2
78 ACUTE KIDNEY INJURY 2
79 AORTIC STENOSIS 2
80 BLOOD CREATININE INCREASED 2
81 BLOOD GLUCOSE DECREASED 2
82 BLOOD PRESSURE INADEQUATELY CONTROLLED 2
83 BREAST CANCER 2
84 BURNING SENSATION 2
85 CARDIAC DISORDER 2
86 DEVICE MALFUNCTION 2
87 DYSGEUSIA 2
88 EYE PRURITUS 2
89 FLUID RETENTION 2
90 GINGIVAL BLEEDING 2
91 HAEMORRHAGE 2
92 HAEMORRHOIDS 2
93 HEPATIC ENZYME INCREASED 2
94 HYPERSENSITIVITY 2
95 HYPOACUSIS 2
96 HYPOTENSION 2
97 INFECTION 2
98 INFUSION SITE PAIN 2
99 INJECTION SITE PAIN 2
100 INJECTION SITE REACTION 2
101 INJECTION SITE SWELLING 2
102 INTENTIONAL OVERDOSE 2
103 INTENTIONAL PRODUCT USE ISSUE 2
104 INTENTIONAL SELF-INJURY 2
105 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 2
106 LOSS OF CONSCIOUSNESS 2
107 LOWER RESPIRATORY TRACT INFECTION 2
108 MALABSORPTION 2
109 METABOLIC ACIDOSIS 2
110 MOVEMENT DISORDER 2
111 MUSCULOSKELETAL DISCOMFORT 2
112 NEEDLE ISSUE 2
113 NEUTROPENIA 2
114 OCULAR HYPERAEMIA 2
115 OVERDOSE 2
116 PARAESTHESIA 2
117 PRESYNCOPE 2
118 PRODUCT PHYSICAL ISSUE 2
119 PRODUCT QUALITY ISSUE 2
120 PROSTATIC SPECIFIC ANTIGEN INCREASED 2
121 PSORIATIC ARTHROPATHY 2
122 PULMONARY EMBOLISM 2
123 RENAL DISORDER 2
124 SEIZURE 2
125 SINUSITIS 2
126 SKIN DISCOLOURATION 2
127 SKIN EXFOLIATION 2
128 SOMNOLENCE 2
129 SOPOR 2
130 SQUAMOUS CELL CARCINOMA 2
131 SURGERY 2
132 SWOLLEN TONGUE 2
133 THERAPEUTIC RESPONSE SHORTENED 2
134 TINNITUS 2
135 URINARY INCONTINENCE 2
136 URINARY RETENTION 2
137 VERTIGO 2
138 WHITE BLOOD CELL COUNT DECREASED 2
139 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
140 ACARIASIS 1
141 ACNE 1
142 ADVERSE DRUG REACTION 1
143 ADVERSE EVENT 1
144 ANGIOEDEMA 1
145 ANGIOMYOLIPOMA 1
146 ANGLE CLOSURE GLAUCOMA 1
147 ANGULAR CHEILITIS 1
148 ANHEDONIA 1
149 ANURIA 1
150 APHASIA 1
151 APPENDICECTOMY 1
152 APPLICATION SITE ERYTHEMA 1
153 APPLICATION SITE PRURITUS 1
154 APPLICATION SITE RASH 1
155 ARTERIAL DISORDER 1
156 ASCITES 1
157 ASTHMA 1
158 ATELECTASIS 1
159 ATRIAL FIBRILLATION 1
160 ATRIAL FLUTTER 1
161 ATROPHY 1
162 BLADDER CANCER 1
163 BLADDER DISCOMFORT 1
164 BLADDER SPASM 1
165 BLISTER 1
166 BLOOD FOLATE DECREASED 1
167 BLOOD GLUCOSE INCREASED 1
168 BLOOD IRON DECREASED 1
169 BLOOD MAGNESIUM DECREASED 1
170 BLOOD POTASSIUM DECREASED 1
171 BLOOD POTASSIUM INCREASED 1
172 BLOOD SODIUM DECREASED 1
173 BLOOD TRIGLYCERIDES INCREASED 1
174 BLOOD UREA ABNORMAL 1
175 BLOOD URINE PRESENT 1
176 BONE DEMINERALISATION 1
177 BONE LOSS 1
178 BRADYCARDIA 1
179 BRADYKINESIA 1
180 BUNDLE BRANCH BLOCK 1
181 C-REACTIVE PROTEIN INCREASED 1
182 CATHETER SITE HAEMORRHAGE 1
183 CEREBRAL HAEMORRHAGE 1
184 CEREBROVASCULAR ACCIDENT 1
185 CHRONIC GASTRITIS 1
186 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1
187 CHRONIC KIDNEY DISEASE 1
188 COELIAC DISEASE 1
189 COLITIS ULCERATIVE 1
190 COLONOSCOPY 1
191 COMPLEX REGIONAL PAIN SYNDROME 1
192 COMPLICATION OF DEVICE REMOVAL 1
193 CONTUSION 1
194 COUGH 1
195 CYST 1
196 DEAFNESS UNILATERAL 1
197 DEEP VEIN THROMBOSIS 1
198 DEFORMITY 1
199 DEVICE BREAKAGE 1
200 DEVICE LEAKAGE 1
201 DEVICE USE ERROR 1
202 DIABETES MELLITUS 1
203 DISTURBANCE IN ATTENTION 1
204 DIVERTICULITIS 1
205 DIVERTICULUM 1
206 DRUG DOSE OMISSION 1
207 DRUG DOSE OMISSION BY DEVICE 1
208 DRUG HYPERSENSITIVITY 1
209 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
210 DRUG INTOLERANCE 1
211 DRY MOUTH 1
212 DYSKINESIA 1
213 DYSPHONIA 1
214 DYSPNOEA EXERTIONAL 1
215 DYSSTASIA 1
216 EAR INFECTION 1
217 ECZEMA 1
218 ELECTROCARDIOGRAM QT PROLONGED 1
219 EMBEDDED DEVICE 1
220 EMOTIONAL DISTRESS 1
221 ENCEPHALITIS 1
222 EPISTAXIS 1
223 ERECTILE DYSFUNCTION 1
224 EXPOSURE DURING PREGNANCY 1
225 EXTRA DOSE ADMINISTERED 1
226 EYE IRRITATION 1
227 EYE PAIN 1
228 FACIAL PAIN 1
229 FACIAL PARALYSIS 1
230 FLANK PAIN 1
231 FLUSHING 1
232 FOETAL EXPOSURE DURING PREGNANCY 1
233 FOOD ALLERGY 1
234 FOOT FRACTURE 1
235 FOREIGN BODY IN REPRODUCTIVE TRACT 1
236 FREQUENT BOWEL MOVEMENTS 1
237 FULL BLOOD COUNT DECREASED 1
238 FUNGAL INFECTION 1
239 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
240 GASTRITIS 1
241 GASTROINTESTINAL EROSION 1
242 GASTROINTESTINAL MUCOSA HYPERAEMIA 1
243 GLOMERULAR FILTRATION RATE DECREASED 1
244 HAEMATOCHEZIA 1
245 HAEMATURIA 1
246 HAEMOGLOBIN DECREASED 1
247 HEAD INJURY 1
248 HEART RATE INCREASED 1
249 HEART RATE IRREGULAR 1
250 HEART VALVE INCOMPETENCE 1
251 HEAVY MENSTRUAL BLEEDING 1
252 HEPATIC CYST 1
253 HEPATITIS ACUTE 1
254 HEPATITIS VIRAL 1
255 HEPATOTOXICITY 1
256 HERPES ZOSTER 1
257 HIP FRACTURE 1
258 HOSPITALISATION 1
259 HYPERAESTHESIA 1
260 HYPERAESTHESIA TEETH 1
261 HYPERGLYCAEMIA 1
262 HYPERHIDROSIS 1
263 HYPERKERATOSIS 1
264 HYPERNATRAEMIA 1
265 HYPERSOMNIA 1
266 HYPOALBUMINAEMIA 1
267 HYPOGLYCAEMIA 1
268 HYPONATRAEMIA 1
269 HYPOVOLAEMIC SHOCK 1
270 IMMUNE-MEDIATED MYOSITIS 1
271 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
272 INCONTINENCE 1
273 INCORRECT DOSE ADMINISTERED 1
274 INFLUENZA 1
275 INFUSION RELATED REACTION 1
276 INFUSION SITE ERYTHEMA 1
277 INFUSION SITE HAEMORRHAGE 1
278 INFUSION SITE INDURATION 1
279 INFUSION SITE INFECTION 1
280 INFUSION SITE IRRITATION 1
281 INFUSION SITE SCAR 1
282 INJECTION SITE BRUISING 1
283 INJECTION SITE DISCHARGE 1
284 INJECTION SITE HAEMORRHAGE 1
285 INJECTION SITE INFECTION 1
286 INJECTION SITE INJURY 1
287 INJECTION SITE IRRITATION 1
288 INJECTION SITE MASS 1
289 INTENTIONAL DOSE OMISSION 1
290 INTERVERTEBRAL DISC DISORDER 1
291 INTESTINAL VILLI ATROPHY 1
292 JOINT STIFFNESS 1
293 LACTIC ACIDOSIS 1
294 LUNG DISORDER 1
295 LYMPHANGIECTASIA INTESTINAL 1
296 MALIGNANT NEOPLASM PROGRESSION 1
297 MASS 1
298 MASTICATION DISORDER 1
299 MEDICAL DEVICE IMPLANTATION 1
300 MENTAL DISORDER 1
301 MENTAL IMPAIRMENT 1
302 MENTAL STATUS CHANGES 1
303 MIDDLE INSOMNIA 1
304 MOBILITY DECREASED 1
305 MOTION SICKNESS 1
306 MOUTH ULCERATION 1
307 MUCOUS STOOLS 1
308 MULTIPLE SCLEROSIS 1
309 MUSCLE ATROPHY 1
310 NAIL INJURY 1
311 NECK PAIN 1
312 NECK SURGERY 1
313 NECROTISING MYOSITIS 1
314 NERVOUS SYSTEM DISORDER 1
315 NERVOUSNESS 1
316 NEURALGIA 1
317 NEUTROPHIL COUNT DECREASED 1
318 NO ADVERSE EVENT 1
319 NOCTURIA 1
320 NODULE 1
321 OCULAR DISCOMFORT 1
322 OLIGURIA 1
323 ORAL DISORDER 1
324 ORAL PAIN 1
325 OROPHARYNGEAL PAIN 1
326 OROPHARYNGEAL PLAQUE 1
327 OSTEOARTHRITIS 1
328 OSTEOPENIA 1
329 OTITIS EXTERNA 1
330 OXYGEN SATURATION ABNORMAL 1
331 PAIN IN JAW 1
332 PAINFUL RESPIRATION 1
333 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1
334 PALMOPLANTAR KERATODERMA 1
335 PALPITATIONS 1
336 PANCYTOPENIA 1
337 PARANASAL SINUS HYPERSECRETION 1
338 PELVIC FRACTURE 1
339 PELVIC INFLAMMATORY DISEASE 1
340 PHILADELPHIA CHROMOSOME POSITIVE 1
341 PHOTOPHOBIA 1
342 PLANTAR ERYTHEMA 1
343 PLEURAL EFFUSION 1
344 PNEUMONIA 1
345 POLYDIPSIA 1
346 POLYMYOSITIS 1
347 POLYURIA 1
348 POOR PERIPHERAL CIRCULATION 1
349 POST PROCEDURAL HAEMORRHAGE 1
350 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1
351 PROCEDURAL PAIN 1
352 PRODUCT COLOUR ISSUE 1
353 PRODUCT DESICCANT ISSUE 1
354 PRODUCT DESIGN ISSUE 1
355 PRODUCT DISTRIBUTION ISSUE 1
356 PRODUCT PHYSICAL CONSISTENCY ISSUE 1
357 PRODUCT PRESCRIBING ISSUE 1
358 PRODUCT STORAGE ERROR 1
359 PRODUCT USE IN UNAPPROVED INDICATION 1
360 PROTHROMBIN TIME PROLONGED 1
361 PULMONARY MASS 1
362 PURPURA 1
363 RADIATION ASSOCIATED HAEMORRHAGE 1
364 RADIUS FRACTURE 1
365 RASH MACULO-PAPULAR 1
366 RASH PRURITIC 1
367 REBOUND EFFECT 1
368 RECTAL HAEMORRHAGE 1
369 RENAL FAILURE 1
370 RESPIRATORY ARREST 1
371 SARS-COV-2 TEST POSITIVE 1
372 SCAR 1
373 SEASONAL ALLERGY 1
374 SEDATION 1
375 SENSITIVE SKIN 1
376 SEROTONIN SYNDROME 1
377 SKIN FISSURES 1
378 SKIN HYPERTROPHY 1
379 SKIN MASS 1
380 SLUGGISHNESS 1
381 SPEECH DISORDER 1
382 SPINAL FRACTURE 1
383 SPONDYLOARTHROPATHY 1
384 STASIS DERMATITIS 1
385 STOMATITIS 1
386 SUSPECTED COUNTERFEIT PRODUCT 1
387 SUSPECTED PRODUCT CONTAMINATION 1
388 SUSPECTED SUICIDE 1
389 SWELLING FACE 1
390 SYNOVITIS 1
391 TACHYPNOEA 1
392 TASTE DISORDER 1
393 TENSION 1
394 THERAPEUTIC RESPONSE DECREASED 1
395 THERAPEUTIC RESPONSE UNEXPECTED 1
396 THERAPY CESSATION 1
397 THERAPY PARTIAL RESPONDER 1
398 THROMBOSIS 1
399 TONGUE DISCOMFORT 1
400 TONSILLAR HYPERTROPHY 1
401 TOOTH FRACTURE 1
402 TOOTH INFECTION 1
403 TOOTH INJURY 1
404 TOOTHACHE 1
405 TORTICOLLIS 1
406 TOXIC SKIN ERUPTION 1
407 TRANSIENT ISCHAEMIC ATTACK 1
408 TREMOR 1
409 UNDERDOSE 1
410 UNEVALUABLE EVENT 1
411 URINE ABNORMALITY 1
412 VIRAL INFECTION 1
413 VISION BLURRED 1
414 VISUAL IMPAIRMENT 1
415 VITAMIN B12 DECREASED 1
416 WALKING AID USER 1
417 WRIST FRACTURE 1